Clinical Trials Logo

Enteric Hyperoxaluria clinical trials

View clinical trials related to Enteric Hyperoxaluria.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT04909723 Terminated - Healthy Volunteers Clinical Trials

Safety, Tolerability, and Pharmacodynamics of NOV-001 in Adult Subjects

Start date: June 2, 2021
Phase: Phase 1/Phase 2
Study type: Interventional

The first stage of this study is a prospective, adaptive, Phase 1, first-in-human, randomized, controlled study evaluating safety, tolerability, and pharmacodynamics of NOV-001 in adult healthy volunteers. The second stage of this study is a prospective, randomized, single-blinded, placebo-controlled study of safety, tolerability, and early efficacy in patients with enteric hyperoxaluria.

NCT ID: NCT03847090 Terminated - Clinical trials for Enteric Hyperoxaluria

Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria

URIROX-2
Start date: August 26, 2019
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine the efficacy, durability and long-term safety of reloxaliase in patients with enteric hyperoxaluria.